Literature DB >> 18234950

Balancing urgency, age and quality of life in organ allocation decisions--what would you do? A survey.

J E Stahl1, A C Tramontano, J S Swan, B J Cohen.   

Abstract

PURPOSE: Explore public attitudes towards the trade-offs between justice and medical outcome inherent in organ allocation decisions.
BACKGROUND: The US Task Force on Organ Transplantation recommended that considerations of justice, autonomy and medical outcome be part of all organ allocation decisions. Justice in this context may be modeled as a function of three types of need, related to age, clinical urgency, and quality of life.
METHODS: A web-based survey was conducted in which respondents were asked to choose between two hypothetical patients who differed in clinical urgency (time to death <1 year), age, pretransplant and post-transplant quality of life, and life expectancy.
RESULTS: A pool of 1600 people were notified via email about the survey; 623 (39%) responded. Respondents preferred giving organs to younger people up to an age difference of <15.4 years (SD 18) and more clinically urgent people up to a difference in urgency of <2.54 months (SD 3). Priority varied with the quality of life of the worst-off patient and the relative status of the patients. If both had worse than average quality of life, respondents preferred the better-off patient. When both had better than average quality of life, they preferred the worse-off patient. In analysis according to age versus clinical urgency, the older the patient, the more urgency needed to receive priority. In quality of life versus clinical urgency, the better the control's quality of life, the more urgency the competing patient required. The worse the patient's post-transplant outcome, the more urgency needed to receive priority.
CONCLUSIONS: It appears that clinical urgency is only one of many factors influencing attitudes about allocation decisions and that respondents may invoke different principles of fairness depending the relative clinical status of patients.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18234950     DOI: 10.1136/jme.2006.018291

Source DB:  PubMed          Journal:  J Med Ethics        ISSN: 0306-6800            Impact factor:   2.903


  6 in total

Review 1.  Systematic Review of Public Preferences for the Allocation of Donor Organs for Transplantation: Principles of Distributive Justice.

Authors:  Carina Oedingen; Tim Bartling; Axel C Mühlbacher; Harald Schrem; Christian Krauth
Journal:  Patient       Date:  2019-10       Impact factor: 3.883

2.  Israeli Medical Experts' Knowledge, Attitudes, and Preferences in Allocating Donor Organs for Transplantation.

Authors:  Amir Elalouf
Journal:  Int J Environ Res Public Health       Date:  2022-06-06       Impact factor: 4.614

3.  Benefit in liver transplantation: a survey among medical staff, patients, medical students and non-medical university staff and students.

Authors:  Christine Englschalk; Daniela Eser; Ralf J Jox; Alexander Gerbes; Lorenz Frey; Derek A Dubay; Martin Angele; Manfred Stangl; Bruno Meiser; Jens Werner; Markus Guba
Journal:  BMC Med Ethics       Date:  2018-02-12       Impact factor: 2.652

4.  Attitudes, knowledge, and preferences of the Israeli public regarding the allocation of donor organs for transplantation.

Authors:  Amir Elalouf; Joseph S Pliskin; Tehila Kogut
Journal:  Isr J Health Policy Res       Date:  2020-05-04

5.  Outcome stagnation of liver transplantation for primary sclerosing cholangitis in the Model for End-Stage Liver Disease era.

Authors:  Johannes Klose; Michelle A Klose; Courtney Metz; Frank Lehner; Michael P Manns; Juergen Klempnauer; Nils Hoppe; Harald Schrem; Alexander Kaltenborn
Journal:  Langenbecks Arch Surg       Date:  2014-06-04       Impact factor: 3.445

6.  Public, medical professionals' and patients' preferences for the allocation of donor organs for transplantation: study protocol for discrete choice experiments.

Authors:  Carina Oedingen; Tim Bartling; Christian Krauth
Journal:  BMJ Open       Date:  2018-10-17       Impact factor: 2.692

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.